|
|
||||||||
Clinical Chemistry, Vol 26, 327-331, Copyright © 1980 by American Association for Clinical Chemistry
F Ceriotti and G Ceriotti
Serum iron is released from transferrin and reduced at pH 1.7 by treating serum with a 10 g/L ascorbic acid solution in 0.1 mol/L HCl. When ferrozine is added to this reagent, it forms a complex with iron that is as intensely colored as at higher pH values, and under these conditions no turbidity is produced. The second major interference, that from copper, is eliminated by adding 1 g of thiosemicarbazide per liter, which at a low pH forms a stable, uncolored complex with copper without affecting the reaction of ferrozine with iron.
The following articles in journals at HighWire Press have cited this article:
![]() |
F. E. Viteri, F. Ali, and J. Tujague Long-Term Weekly Iron Supplementation Improves and Sustains Nonpregnant Women's Iron Status as Well or Better than Currently Recommended Short-Term Daily Supplementation J. Nutr., November 1, 1999; 129(11): 2013 - 2020. [Abstract] [Full Text] |
||||
![]() |
K. O O'Brien, N. Zavaleta, L. E Caulfield, D.-X. Yang, and S. A Abrams Influence of prenatal iron and zinc supplements on supplemental iron absorption, red blood cell iron incorporation, and iron status in pregnant Peruvian women Am. J. Clinical Nutrition, March 1, 1999; 69(3): 509 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamanishi, S. Kimura, S. Iyama, Y. Yamaguchi, and T. Yanagihara Fully automated measurement of total iron-binding capacity in serum Clin. Chem., December 1, 1997; 43(12): 2413 - 2417. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |